QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: A one year follow-up study

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Belay, Mulugeta ^a,b   Legesse, Mengistu ^a   Dagne, Daniel ^a,c   Mihret, Adane ^d   Bekele, Yonas ^d   Medhin, Girmay ^a   Bjune, Gunnar ^b   Abebe, Fekadu ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF OSLO   (Norway)

^c Amhara Regional Health Bureau   (Ethiopia)

^d ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

Author keywords

Contacts; Conversion; Ethiopia; Patients; QuantiFERON TB Gold In Tube; Reversion; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; FOLLOW UP; HOUSEHOLD; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS TEST KIT; SCREENING TEST; SEROCONVERSION; SPUTUM SMEAR; CONTACT EXAMINATION; EVALUATION STUDY; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; TRANSMISSION; TUBERCULOSIS, PULMONARY;

ADULT; CONTACT TRACING; ETHIOPIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; TUBERCULOSIS, PULMONARY;

EID: 84924337346     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0654-5     Document Type: Article

References (28)

1. WHO: Global Tuberculosis Report. Geneva: WHO; 2013.
2. WHO: The STOP TB STRATEGY: Building on and Enhancing DOTS to Meet the TB-Related Millennium Development Goals. Geneva: WHO; 2006.
3. Borgdorff MW, Sebek M, Geskus RB, Kremer K, Kalisvaart N, van Soolingen D: The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach. Int J Epidemiol 2011, 40(4):964-970.
4. Hart PD, Sutherland I: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 1977, 2:293-295.
5. Federal Minstry of Health: Guidelines for Clinical and Programmatic Management of TB, Leprosy and TB/HIV in Ethiopia. Addis Ababa: MOH; 2012.
6. Menzies D: Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999, 159(1):15-21.
7. Pai M, Zwerling A, Menzies D: Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149(3):177-184.
8. Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146(5):340-354.
9. Lee SW, Lee SH, Yim JJ: Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort. Infection 2012, 40(4):431-435.
10. Ringshausen FC, Nienhaus A, Schablon A, Schlosser S, Schultze-Werninghaus G, Rohde G: Predictors of persistently positive Mycobacterium-tuberculosis -specific interferon-gamma responses in the serial testing of health care workers. BMC Infect Dis 2010, 10:220.
11. Shah M, Kasambira TS, Adrian PV, Madhi SA, Martinson NA, Dorman SE: Longitudinal analysis of QuantiFERON-TB gold in-tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study. PLoS One 2011, 6(10):e26787.
12. Machingaidze S, Verver S, Mulenga H, Abrahams DA, Hatherill M, Hanekom W, Hussey GD, Mahomed H: Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med 2012, 186(10):1051-1056.
13. Population Census Commission: Summary and Statistical Report of the 2007 Population and Housing Census Results. Addis Ababa: CSA; 2007.
14. Federal Ministry of Health: Guidelines for HIV Counselling and Testing in Ethiopia. Addis Ababa: MOH; 2007.
15. Jensen AV, Jensen L, Faurholt-Jepsen D, Aabye MG, Praygod G, Kidola J, Faurholt-Jepsen M, Changalucha J, Range N, Krarup H, Friis H, Andersen AB: The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-gamma release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania. PLoS One 2013, 8(5):e64008.
16. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, Goswami K, Reddy MV, Kalantri A, Hill PC, Menzies D, Hopewell PC: T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009, 13(1):84-92.
17. Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, Abebe F: Community-based cross-sectional survey of latent tuberculosis infection in afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-tube and tuberculin skin test. BMC Infect Dis 2011, 11:89.
18. Belay M, Bjune G, Ameni G, Abebe F: Diagnostic and treatment delay among Tuberculosis patients in Afar Region, Ethiopia: a cross-sectional study. BMC Public Health 2012, 12:369.
19. Mahan CS, Zalwango S, Thiel BA, Malone LL, Chervenak KA, Baseke J, Dobbs D, Stein CM, Mayanja H, Joloba M, Whalen CC, Boom WH: Innate and adaptive immune responses during acute M. tuberculosis infection in adult household contacts in Kampala, Uganda. Am J Trop Med Hyg 2012, 86(4):690-697.
20. Aichelburg MC, Reiberger T, Breitenecker F, Mandorfer M, Makristathis A, Rieger A: Reversion and conversion of interferon-gamma release assay results in HIV-1-infected individuals. J Infect Dis 2014, 209(5):729-733.
21. Kebede AH, Alebachew Z, Tsegaye F, Lemma E, Abebe A, Agonafir M, Kebede AJ, Demissie D, Girmachew F, Yaregal Z, Dana F, Getahun M, Fiseha Y, Meaza A, Dirse N, Timimi H, Sismanidis C, Tadolini M, Onozaki I: The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011. Int J Tuberc Lung Dis 2014, 18(6):635-639.
22. Hur YG, Gorak-Stolinska P, Lalor MK, Mvula H, Floyd S, Raynes J, Ben-Smith A, Fitchett JR, Flanagan KL, Burl S, Ota MO, Crampin AC, Smith SG, Dockrell HM: Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UK. BMC Infect Dis 2014, 14:184.
23. Rakotosamimanana N, Raharimanga V, Andriamandimby SF, Soares JL, Doherty TM, Ratsitorahina M, Ramarokoto H, Zumla A, Huggett J, Rook G, Richard V, Gicquel B, Rasolofo-Razanamparany V, VACSEL/VACSIS Study Group: Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clin VaccineImmunol 2010, 17(7):1094-1103.
24. Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah D, Lugos MD, Donkor SA, Adegbola RA, Brookes RH: Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006, 6:66.
25. Komiya K, Ariga H, Nagai H, Kurashima A, Shoji S, Ishii H, Nakajima Y: Reversion rates of QuantiFERON-TB Gold are related to pre-treatment IFN-gamma levels. J Infect 2011, 63(1):48-53.
26. Lee SW, Lee CT, Yim JJ: Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infect Dis 2010, 10:300.
27. Orme IM: A new unifying theory of the pathogenesis of tuberculosis. Tuberculosis 2014, 94(1):8-14.
28. Denkinger CM, Pai M, Patel M, Menzies D: Gamma interferon release assay for monitoring of treatment response for active tuberculosis: an explosion in the spaghetti factory. J Clin Microbiol 2013, 51(2):607-610.